A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

NCT06213259 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: KD6005
DRUG: Placebo

Sponsor

Shanghai Kanda Biotechnology Co., Ltd.